FI891873A0 - Menetelmä uuden lääkeaineena käyttökelpoisen polypeptidin valmistamiseksi - Google Patents

Menetelmä uuden lääkeaineena käyttökelpoisen polypeptidin valmistamiseksi

Info

Publication number
FI891873A0
FI891873A0 FI891873A FI891873A FI891873A0 FI 891873 A0 FI891873 A0 FI 891873A0 FI 891873 A FI891873 A FI 891873A FI 891873 A FI891873 A FI 891873A FI 891873 A0 FI891873 A0 FI 891873A0
Authority
FI
Finland
Prior art keywords
preparing
same
drug
preparation
polypeptide useful
Prior art date
Application number
FI891873A
Other languages
English (en)
Swedish (sv)
Other versions
FI92708B (fi
FI891873A (fi
FI92708C (fi
Inventor
Takanori Nakamura
Sadaaki Iwanaga
Motonori Ohno
Kyosuke Miyazaki
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of FI891873A publication Critical patent/FI891873A/fi
Publication of FI891873A0 publication Critical patent/FI891873A0/fi
Publication of FI92708B publication Critical patent/FI92708B/fi
Application granted granted Critical
Publication of FI92708C publication Critical patent/FI92708C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI891873A 1987-08-21 1989-04-19 Menetelmä uuden lääkeaineena käyttökelpoisen polypeptidin valmistamiseksi FI92708C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP20625887 1987-08-21
JP20625887 1987-08-21
PCT/JP1988/000823 WO1989001492A1 (en) 1987-08-21 1988-08-19 Novel polypeptide and method for preparing the same
JP8800823 1988-08-19

Publications (4)

Publication Number Publication Date
FI891873A FI891873A (fi) 1989-04-19
FI891873A0 true FI891873A0 (fi) 1989-04-19
FI92708B FI92708B (fi) 1994-09-15
FI92708C FI92708C (fi) 1994-12-27

Family

ID=16520353

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891873A FI92708C (fi) 1987-08-21 1989-04-19 Menetelmä uuden lääkeaineena käyttökelpoisen polypeptidin valmistamiseksi

Country Status (13)

Country Link
US (2) US5068314A (fi)
EP (1) EP0343248B1 (fi)
JP (1) JP2710653B2 (fi)
KR (1) KR970001811B1 (fi)
CN (1) CN1031193C (fi)
AT (1) ATE88480T1 (fi)
AU (1) AU642089B2 (fi)
CA (2) CA1337781C (fi)
DE (1) DE3880481T2 (fi)
DK (1) DK193589A (fi)
FI (1) FI92708C (fi)
NO (2) NO175372C (fi)
WO (1) WO1989001492A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
RO109653B1 (ro) * 1990-09-11 1995-04-28 Seikagaku Kogyo Co Ltd Polipeptide
DE69211973T2 (de) * 1991-12-25 1996-12-19 Maruha Corp Reagenzien und Verfahren zur Bestimmung von Beta-Glucanen
JP3361830B2 (ja) * 1992-03-30 2003-01-07 生化学工業株式会社 抗菌性組成物及びそれを有効成分とする薬剤
DE69219590T2 (de) * 1992-05-30 1997-11-27 Marko Duvnjak BPC-Peptide, deren Herstellung und Verwendung
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
CA2112776C (en) * 1993-01-21 2002-11-12 Masakazu Tsuchiya Process for inhibiting activity of endotoxin
EP0664814A1 (en) 1993-08-18 1995-08-02 MorphoSys AG Lipopolysaccharide-binding and neutralizing peptides
WO1995010534A1 (en) * 1993-10-14 1995-04-20 Seikagaku Corporation Polypeptide and anti-hiv agent prepared therefrom
KR100257310B1 (ko) * 1996-12-21 2000-05-15 정몽규 트렁크 리드 개폐장치
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
CN100389140C (zh) * 2006-05-12 2008-05-21 北京理工大学 由聚肽-b-聚四氢呋喃-b-聚肽三嵌段共聚物制备纳米及微米级自组装体的方法
US8715685B2 (en) * 2009-07-14 2014-05-06 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for HIV disease
CN108623659B (zh) * 2018-03-17 2021-09-14 中国海洋大学 一种氨基酸全部选用d型氨基酸的抗菌肽合成方法
WO2021183061A1 (en) * 2020-03-13 2021-09-16 Vet Products Research And Innovation Center Company Limited Antimicrobial peptides for inhibition of pathogenic microorganisms in digestive and respiratory tracts in animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663435A (en) * 1982-12-06 1987-05-05 Merck & Co., Inc. Bridged cyclic hexapeptide somatostatin analogs
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation

Also Published As

Publication number Publication date
WO1989001492A1 (en) 1989-02-23
EP0343248A1 (en) 1989-11-29
CN1031379A (zh) 1989-03-01
EP0343248B1 (en) 1993-04-21
NO940078D0 (no) 1994-01-10
NO178663C (no) 1996-05-08
DE3880481D1 (de) 1993-05-27
JPH02500194A (ja) 1990-01-25
DK193589D0 (da) 1989-04-20
AU642089B2 (en) 1993-10-07
CA1337781C (en) 1995-12-19
AU620345B2 (en) 1992-02-20
ATE88480T1 (de) 1993-05-15
DE3880481T2 (de) 1993-09-09
DK193589A (da) 1989-06-16
NO940078L (no) 1989-05-09
NO178663B (no) 1996-01-29
NO891572D0 (no) 1989-04-18
KR970001811B1 (ko) 1997-02-15
AU2311388A (en) 1989-03-09
US5416194A (en) 1995-05-16
FI92708B (fi) 1994-09-15
FI891873A (fi) 1989-04-19
US5068314A (en) 1991-11-26
NO175372B (no) 1994-06-27
NO891572L (no) 1989-05-09
AU1702892A (en) 1992-07-16
CN1031193C (zh) 1996-03-06
KR890701624A (ko) 1989-12-21
FI92708C (fi) 1994-12-27
CA1337782C (en) 1995-12-19
NO175372C (no) 1994-10-05
JP2710653B2 (ja) 1998-02-10

Similar Documents

Publication Publication Date Title
FI891873A0 (fi) Menetelmä uuden lääkeaineena käyttökelpoisen polypeptidin valmistamiseksi
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
HUT49891A (en) Process for production of peptides with antiaggregation effect and medical compositions containing them
CA2187083A1 (fr) Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation
KR960031602A (ko) 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조 방법
US4777243A (en) Immuno stimulant substances derived from bovine casein and compositions containing the same
Craig et al. Purity studies on polypeptide antibiotics: bacitracin
AU1377092A (en) Peptides for treatment
Kuromizu et al. Reexamination of the primary structure of an antitumor protein, neocarzinostatin
KR890003409A (ko) 점막 투여시 흡수 촉진제로서의 시클릭 펩티드
AU1599892A (en) Novel polypeptides with affinity to lipopolysaccharides and their uses
AU585167B2 (en) Novel substrate peptides
RU94024392A (ru) Минерально-аминокислотный концентрат
EP0153710A2 (en) Novel toxoids of elastase of pseudomonas aeruginosa origin
KR790001842B1 (ko) 신규 폴리펩티드의 제조법
RU94046096A (ru) Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов
UA28084C2 (uk) Протипухлинний засіб, виділений з слизової кишечника, спосіб його виділення
RU97114945A (ru) Белки против ожирения
NO922229L (no) Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma
TH4137B (th) ลำดับ dna ที่มีรหัสของเซอร์เฟสแอนติเจนโปรตีน p31 ที่ดัดแปลงของไวรัสเฮพพาทิทิส บี
TH4070A (th) ลำดับ dna ที่มีรหัสของเซอร์เฟสแอนติเจนโปรตีน p31 ที่ดัดแปลงของไวรัสเฮพพาทิทิส บี

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: SEIKAGAKU KOGYO CO. LTD.